XML 62 R31.htm IDEA: XBRL DOCUMENT v3.26.1
Share Capital (Tables)
12 Months Ended
Dec. 31, 2025
Stockholders' Equity Note [Abstract]  
Schedule of the effect of share-based compensation on the statements of operations
   
Year ended
   
Year ended
   
Year ended
 
 
 
December 31,
   
December 31,
   
December 31,
 
 
 
2025
   
2024
    2023  
   
USD thousands
   
USD thousands
   
USD thousands
 
Research and development
   
158
     
401
     
407
 
General and administrative
   
465
     
216
     
1,084
 
                         
Total share-based compensation expenses
   
623
     
617
     
1,491
 
Schedule of number and weighted average exercise prices of option
   
Weighted average
exercise price
   
Number
of options
   
Weighted
average
remaining contractual life (in years)
   
Weighted
average
exercise price
   
Number
of options
   
Weighted
average
remaining contractual life (in years)
 
   
2024
   
2024
   
2024
   
2023
   
2023
   
2023
 
Outstanding at January 1
   
0.16
     
29,873,100
     
5.99
     
0.33
     
35,191,540
     
7.42
 
Exercised
   
-
     
-
     
-
     
-
     
-
     
-
 
Forfeited
   
0.19
     
(667,820
)
   
-
     
0.39
     
(20,373,620
)
   
-
 
Granted
   
0.03
     
2,845,020
     
8.56
     
0.07
     
15,055,180
     
5.86
 
                                                 
Outstanding at December 31
   
0.15
     
32,050,300
     
7.34
     
0.16
     
29,873,100
     
5.99
 
 
   
Weighted average
exercise price
   
Number
of options
   
Weighted
average
remaining contractual life (in years)
   
Weighted
average
exercise price
   
Number
of options
   
Weighted
average
remaining contractual life (in years)
 
   
2025
   
2025
   
2025
   
2024
   
2024
   
2024
 
Outstanding at January 1
   
0.15
     
32,050,300
     
7.34
     
0.16
     
29,873,100
     
5.99
 
Exercised
   
0.03
     
(449,920
)
   
-
     
-
     
-
     
-
 
Forfeited
   
0.11
     
(4,869,540
)
   
-
     
0.19
     
(667,820
)
   
-
 
Granted
   
0.06
     
4,761,880
     
9.30
     
0.03
     
2,845,020
     
8.56
 
                                                 
Outstanding at December 31
   
0.14
     
31,492,720
     
6.71
     
0.15
     
32,050,300
     
7.34
 
Schedule of Unvested RSA
   
Number of RSAs
 
RSA
 
2025
 
Unvested at beginning of the year
   
6,443,900
 
Granted
   
5,870,980
 
Vested
   
(1,433,120
)
Forfeited
   
(810,400
)
         
Outstanding at December 31, 2025
   
10,071,360
 
Schedule of assumptions used to calculate the fair value of the options
   
2025 grants of Options
 
Weighted average share price (in U.S. dollar)(a)
   
0.05
 
Exercise price (in U.S. dollar)
   
0.06-0.08
 
Expected life of options (in years)(b)
   
5.44-5.5
 
Expected volatility(c)
   
96%-105.2
%
Risk-free interest rate(d)
   
4.09%-4.19
%
Dividend yield
   
0
%